First name
D.
Last name
Segal
Scherzer-Attali, R., Convertino, M., Pellarin, R., Gazit, E., Segal, D., & Caflisch, A. (2013). Methylations of tryptophan-modified naphthoquinone affect its inhibitory potential toward Aβ aggregation. The Journal of Physical Chemistry B, 117(6), 1780-1789. https://doi.org/10.1021/jp309066p (Original work published)
Frydman-Marom, A., Convertino, M., Pellarin, R., Lampel, A., Shaltiel-Karyo, R., Segal, D., … Gazit, E. (2011). Structural basis for inhibiting β-amyloid oligomerization by a non-coded β-breaker-substituted endomorphin analogue. ACS Chemical Biology, 6(11), 1265-1276. https://doi.org/10.1021/cb200103h (Original work published)
Scherzer-Attali, R., Pellarin, R., Convertino, M., Frydman-Marom, A., Egoz-Matia, N., Peled, S., … Segal, D. (2010). Complete phenotypic recovery of an Alzheimer’s disease model by a quinone-tryptophan hybrid aggregation inhibitor. PLoS One, 5(6), e11101. https://doi.org/10.1371/journal.pone.0011101 (Original work published 2010)